These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

382 related articles for article (PubMed ID: 20090075)

  • 1. Alpha1-antitrypsin deficiency: forgotten etiology.
    Kaplan A; Cosentino L
    Can Fam Physician; 2010 Jan; 56(1):19-24. PubMed ID: 20090075
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Indications for active case searches and intravenous alpha-1 antitrypsin treatment for patients with alpha-1 antitrypsin deficiency chronic pulmonary obstructive disease: an update.
    Casas F; Blanco I; Martínez MT; Bustamante A; Miravitlles M; Cadenas S; Hernández JM; Lázaro L; Rodríguez E; Rodríguez-Frías F; Torres M; Lara B
    Arch Bronconeumol; 2015 Apr; 51(4):185-92. PubMed ID: 25027067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnosis and treatment of lung disease associated with alpha one-antitrypsin deficiency: A position statement from the Thoracic Society of Australia and New Zealand.
    Dummer J; Dobler CC; Holmes M; Chambers D; Yang IA; Parkin L; Smith S; Wark P; Dev A; Hodge S; Dabscheck E; Gooi J; Samuel S; Knowles S; Holland AE
    Respirology; 2020 Mar; 25(3):321-335. PubMed ID: 32030868
    [TBL] [Abstract][Full Text] [Related]  

  • 4. α1 Antitrypsin deficiency: current best practice in testing and augmentation therapy.
    Campos MA; Lascano J
    Ther Adv Respir Dis; 2014 Oct; 8(5):150-61. PubMed ID: 25013223
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advances in managing COPD related to α
    Craig TJ; Henao MP
    Allergy; 2018 Nov; 73(11):2110-2121. PubMed ID: 29984428
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term clinical outcomes following treatment with alpha 1-proteinase inhibitor for COPD associated with alpha-1 antitrypsin deficiency: a look at the evidence.
    Rahaghi FF; Miravitlles M
    Respir Res; 2017 May; 18(1):105. PubMed ID: 28558837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of lung disease in alpha-1 antitrypsin deficiency: a systematic review.
    Edgar RG; Patel M; Bayliss S; Crossley D; Sapey E; Turner AM
    Int J Chron Obstruct Pulmon Dis; 2017; 12():1295-1308. PubMed ID: 28496314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alpha-1 antitrypsin (AAT) augmentation therapy in individuals with the PI*MZ genotype: a pro/con debate on a working hypothesis.
    Barjaktarevic I; Miravitlles M
    BMC Pulm Med; 2021 Mar; 21(1):99. PubMed ID: 33757485
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The important role of primary care providers in the detection of alpha-1 antitrypsin deficiency.
    Lascano JE; Campos MA
    Postgrad Med; 2017 Nov; 129(8):889-895. PubMed ID: 28929906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Understanding alpha-1 antitrypsin deficiency: A review with an allergist's outlook.
    Henao MP; Craig TJ
    Allergy Asthma Proc; 2017 Mar; 38(2):98-107. PubMed ID: 28234047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of complement component 3 is associated with airways disease and pulmonary emphysema in alpha-1 antitrypsin deficiency.
    O'Brien ME; Fee L; Browne N; Carroll TP; Meleady P; Henry M; McQuillan K; Murphy MP; Logan M; McCarthy C; McElvaney OJ; Reeves EP; McElvaney NG
    Thorax; 2020 Apr; 75(4):321-330. PubMed ID: 31959730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent advances in understanding and treating COPD related to α
    Henao MP; Craig TJ
    Expert Rev Respir Med; 2016 Dec; 10(12):1281-1294. PubMed ID: 27771979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alpha1-antitrypsin deficiency: incidence and implications.
    Richmond RJ; Zellner KM
    Dimens Crit Care Nurs; 2005; 24(6):255-60; quiz 261-2. PubMed ID: 16327507
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alpha1-antitrypsin deficiency: An updated review.
    Mornex JF; Traclet J; Guillaud O; Dechomet M; Lombard C; Ruiz M; Revel D; Reix P; Cottin V
    Presse Med; 2023 Sep; 52(3):104170. PubMed ID: 37517655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SPARTA clinical trial design: exploring the efficacy and safety of two dose regimens of alpha1-proteinase inhibitor augmentation therapy in alpha1-antitrypsin deficiency.
    Sorrells S; Camprubi S; Griffin R; Chen J; Ayguasanosa J
    Respir Med; 2015 Apr; 109(4):490-9. PubMed ID: 25727857
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is an integrative laboratory algorithm more effective in detecting alpha-1-antitrypsin deficiency in patients with premature chronic obstructive pulmonary disease than AAT concentration based screening approach?
    Beletic A; Dudvarski-Ilic A; Milenkovic B; Nagorni-Obradovic L; Ljujic M; Djordjevic V; Mirkovic D; Radojkovic D; Majkic-Singh N
    Biochem Med (Zagreb); 2014; 24(2):293-8. PubMed ID: 24969923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PredictAAT: Accounting for Inflammation in the Diagnosis of Alpha 1 Antitrypsin Deficiency.
    Kueppers F
    COPD; 2020 Dec; 17(6):619-622. PubMed ID: 32862719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [α1-Antitrypsin deficiency].
    Hirai T
    Nihon Rinsho; 2016 May; 74(5):869-73. PubMed ID: 27254961
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alpha-1-Antitrypsin Deficiency: Disease Management and Learning from Studies.
    Greulich T
    COPD; 2017 Mar; 14(sup1):S8-S11. PubMed ID: 28306355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improving the Lives of Patients with Alpha-1 Antitrypsin Deficiency.
    Sandhaus RA; Strange C; Zanichelli A; Skålvoll K; Koczulla AR; Stockley RA
    Int J Chron Obstruct Pulmon Dis; 2020; 15():3313-3322. PubMed ID: 33328731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.